Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa university

Trial Profile

Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa university

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 May 2016

At a glance

  • Drugs Edoxaban (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
  • Indications Pulmonary embolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top